Junjiang Liu
About
In The Last Decade
Junjiang Liu
65 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Molecular Biology 423
- Oncology 316
- Cancer Research 253
- Civil and Structural Engineering 205
- Immunology 189
Countries citing papers authored by Junjiang Liu
This map shows the geographic impact of Junjiang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junjiang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junjiang Liu more than expected).
Fields of papers citing papers by Junjiang Liu
This network shows the impact of papers produced by Junjiang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junjiang Liu. The network helps show where Junjiang Liu may publish in the future.
Co-authorship network of co-authors of Junjiang Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Junjiang Liu. A scholar is included among the top collaborators of Junjiang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junjiang Liu. Junjiang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | Curcumin-primed olfactory mucosa-derived mesenchymal stem cells mitigate cerebral ischemia/reperfusion injury-induced neuronal PANoptosis by modulating microglial polarization breakdown → | 100 |
| 5 | 12 | |
| 6 | 1 | |
| 7 | 0 | |
| 8 | 0 | |
| 9 | 2 | |
| 10 | 3 | |
| 11 | 3 | |
| 12 | 1 | |
| 13 | 3 | |
| 14 | 23 | |
| 15 | 6 | |
| 16 | 49 | |
| 17 | 5 | |
| 18 | 1 | |
| 19 | 8 | |
| 20 | Multi-center,randomized,double-masked,double-mimic active-controlled clinical trial of glipizide/metformin hydrochloride tablets for patients with type 2 diabetes | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.